These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11130529)

  • 1. Ep-CAM overexpression in breast cancer as a predictor of survival.
    Gastl G; Spizzo G; Obrist P; Dünser M; Mikuz G
    Lancet; 2000 Dec; 356(9246):1981-2. PubMed ID: 11130529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Simon R; Spichtin H; Maurer R; Metzger U; von Castelberg B; Bart R; Stopatschinskaya S; Köchli OR; Haas P; Mross F; Zuber M; Dietrich H; Bischoff S; Mirlacher M; Sauter G; Gastl G
    Breast Cancer Res Treat; 2004 Aug; 86(3):207-13. PubMed ID: 15567937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
    Spizzo G; Went P; Dirnhofer S; Obrist P; Moch H; Baeuerle PA; Mueller-Holzner E; Marth C; Gastl G; Zeimet AG
    Gynecol Oncol; 2006 Nov; 103(2):483-8. PubMed ID: 16678891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
    Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
    Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
    Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
    Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.
    Varga M; Obrist P; Schneeberger S; Mühlmann G; Felgel-Farnholz C; Fong D; Zitt M; Brunhuber T; Schäfer G; Gastl G; Spizzo G
    Clin Cancer Res; 2004 May; 10(9):3131-6. PubMed ID: 15131054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic Trop-1/Ep-CAM overexpression is associated with a favorable outcome in node-positive breast cancer.
    Alberti S; Ambrogi F; Boracchi P; Fornili M; Querzoli P; Pedriali M; La Sorda R; Lattanzio R; Tripaldi R; Piantelli M; Biganzoli E; Coradini D
    Jpn J Clin Oncol; 2012 Dec; 42(12):1128-37. PubMed ID: 23072840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.
    Schmidt M; Hasenclever D; Schaeffer M; Boehm D; Cotarelo C; Steiner E; Lebrecht A; Siggelkow W; Weikel W; Schiffer-Petry I; Gebhard S; Pilch H; Gehrmann M; Lehr HA; Koelbl H; Hengstler JG; Schuler M
    Clin Cancer Res; 2008 Sep; 14(18):5849-55. PubMed ID: 18794096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.
    Schmidt M; Petry IB; Böhm D; Lebrecht A; von Törne C; Gebhard S; Gerhold-Ay A; Cotarelo C; Battista M; Schormann W; Freis E; Selinski S; Ickstadt K; Rahnenführer J; Sebastian M; Schuler M; Koelbl H; Gehrmann M; Hengstler JG
    Breast Cancer Res Treat; 2011 Feb; 125(3):637-46. PubMed ID: 20352488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
    Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
    J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
    Went P; Vasei M; Bubendorf L; Terracciano L; Tornillo L; Riede U; Kononen J; Simon R; Sauter G; Baeuerle PA
    Br J Cancer; 2006 Jan; 94(1):128-35. PubMed ID: 16404366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity.
    Akita H; Nagano H; Takeda Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Takahashi H; Ohigashi H; Tomita Y; Ishikawa O; Mori M; Doki Y
    Oncogene; 2011 Aug; 30(31):3468-76. PubMed ID: 21399662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival.
    Spizzo G; Gastl G; Wolf D; Gunsilius E; Steurer M; Fong D; Amberger A; Margreiter R; Obrist P
    Br J Cancer; 2003 Feb; 88(4):574-8. PubMed ID: 12592372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
    Joo M; Kim H; Kim MK; Yu HJ; Kim JP
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific targeting of Ep-CAM in various carcinomas by novel monoclonal antibodies.
    Sithambaram D; Palanivelu S; Subramanian K; Sahoo S; Verma RS
    Hybridoma (Larchmt); 2011 Dec; 30(6):511-8. PubMed ID: 22149275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
    Piyathilake CJ; Frost AR; Weiss H; Manne U; Heimburger DC; Grizzle WE
    Hum Pathol; 2000 Apr; 31(4):482-7. PubMed ID: 10821496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker.
    Stoecklein NH; Siegmund A; Scheunemann P; Luebke AM; Erbersdobler A; Verde PE; Eisenberger CF; Peiper M; Rehders A; Esch JS; Knoefel WT; Hosch SB
    BMC Cancer; 2006 Jun; 6():165. PubMed ID: 16796747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal thymic expression of epithelial cell adhesion molecule (EP-CAM) in New Zealand Black (NZB) mice.
    Taguchi N; Hashimoto Y; Naiki M; Farr AG; Boyd RL; Ansari AA; Shultz LD; Kotzin BL; Dorshkind K; Ikehara S; Gershwin ME
    J Autoimmun; 1999 Dec; 13(4):393-404. PubMed ID: 10585755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of Ep-CAM and cyclin D1 and their clinical significance in gallbladder carcinoma].
    Ren G; Yu G; Liu LW; Ma L
    Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):841-4. PubMed ID: 20137349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.
    Ghebeh H; Sleiman GM; Manogaran PS; Al-Mazrou A; Barhoush E; Al-Mohanna FH; Tulbah A; Al-Faqeeh K; Adra CN
    BMC Cancer; 2013 Jun; 13():289. PubMed ID: 23768049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.